Status of infection in young hemophilia patients in Münster

Seminars in Thrombosis and Hemostasis

Volumn 28, Issue SUPPL. 1, 2002, Pages 47-50

  Pollmann, Hartmut ^a   Richter, Hendrik ^a  

^a Praxis Diagn Therap von Blutger   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BERIATE HS; BLOOD CLOTTING FACTOR 8 CONCENTRATE;

CHILDHOOD DISEASE; CONFERENCE PAPER; CRYOPRECIPITATE; DRUG MANUFACTURE; DRUG SYNTHESIS; HEMOPHILIA; HUMAN; INFECTION RISK; PASTEURIZATION; PRIORITY JOURNAL; QUALITY OF LIFE; VIRUS INACTIVATION;

EID: 0036229590     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-30195     Document Type: Conference Paper

References (29)

1. High-potency antihaemophiliac factor concentrate prepared from cryoglobulin precipitate
2. Entwicklung und probleme einer optimalen ärztlichen versorgung in der Bundesrepublik Deutschland
3. Hepatitis A virus infections in Belgian children
4. Asymptomatic structural liver disease in hemophilia
5. Hämophilie
6. Hepatitishäufigkeit, HB-antigen-frequenz bei patienten des Hämophiliezentrums Heidelberg
7. Chronic liver dysfunction in multitransfused hemophiliacs
8. Viral exposure and abnormal liver function in haemophilia
9. Hepatitis epidemiology in Swiss hemophiliacs
10. Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen
11. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease
12. Prevalence of hepatitis G virus RNA in a monocentric population of French haemophiliacs
13. High rates of hepatitis G virus infection in multitransfused patients with hemophilia
14. Hepatitis G virus infection in patients with bleeding disorders
15. Prevalence of HIV-antibodies in patients with haemophilia in Hungary
16. Self-therapy for haemophilia in Norway
17. AIDS and haemophilla: A study among Dutch haemophiliacs on the psychological impact of the AIDS threat, the prevalence of HIV antibodies and the adoption of measures to prevent HIV infection
18. Low AIDS attack rate among Dutch haemophiliacs compared to homosexual men: A correlate of HIV antigenaemia frequencies
19. Epidemiology of hemophilia and of HIV infection in Italy
20. Prevalence of antibody to HTLV-III in haemophiliacs in the United Kingdom
21. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France
22. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany
23. AIDS and hemophilia: Experience in the La Paz Hemophilia Center
24. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate
25. Faktor VIII-konzentrat - Hepatitissicher: Fortschritte in der behandlung der hämophilie A
26. Faktor VIII-konzentrat, hochgereinigt und in lösung erhitzt
27. A factor VIII concentrate, highly purified and heated in solution
28. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with haemophilia and no previous transfusions
29. Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of haemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate